A new CAR-T therapy shows efficacy in preclinical models of hard-to-treat leukemias
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a st...
News from Institute of Cancer and Blood Diseases
A multicenter study identifies the differentiated risk of colorectal cancer depending on the affected gene in Lynch syndrome
Researchers from Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Center, have led a study analyzing how genetic m...
Clínic Barcelona Comprehensive Cancer Center appoints new heads of the Medical Oncology and Hematology departments to strengthen clinical and scientific developmen
The Clínic Barcelona Comprehensive Cancer Center (4CB), driven by Hospital Clínic Barcelona, IDIBAPS, and the University of Barcelona, has announce...
New study validates the prognostic value of the HER2DX test in HER2-positive breast cancer
Researchers from the Clínic Barcelona Comprehensive Cancer Center—driven by Hospital Clínic Barcelona, IDIBAPS, and the University of Barcelona—tog...
The Clínic Barcelona Comprehensive Cancer Center presents its latest advances at the ASCO 2025 Global Oncology Congress
The Clínic Barcelona Comprehensive Cancer Center (4CB), driven by Hospital Clínic, IDIBAPS, and the University of Barcelona, strengthens its intern...
Hospital Clínic-IDIBAPS, pioneer in CAR T-cell therapies for cancer with over 500 patients treated
Hospital Clínic-IDIBAPS is the only hospital in Europe to have fully developed two academic CAR T-cell therapies that have been approved by a regul...
Olga Federico: “I was happy to go to the chemotherapy sessions, because it meant that there was hope"
“I didn’t know what my present or my future would be like. I was very scared”, recalls Olga Federico of the time when she was diagnosed with breas...
The Campus Clínic presents the Clínic Barcelona Comprehensive Cancer Center: a new model of international excellence in oncology
The creation of the Clínic Barcelona Comprehensive Cancer Center represents a step forward in the integration of care, clinical research, translati...
A new dual CAR-T therapy is developed against non-Hodgkin lymphoma
Researchers at IDIBAPS- Hospital Clínic have developed and validated a new CAR-T therapy called ARI0003 at a preclinical level. The new therapy com...
Researchers identify a link between the immune system and survival after breast cancer
Researchers from Hospital Clínic-IDIBAPS have led a study that has found a correlation between anti-tumour immunological activity and longevity in...